Table 1 Characteristics of the study population who received monthly follow-up or bimonthly follow-up
Monthly Visit (n = 1686) | Bimonthly Visit (n = 726) | Absolute Standardized Difference, % | P Value | |
|---|---|---|---|---|
Demographics | ||||
Age | 66.5 ± 5.0 | 66.3 ± 5.2 | 4.2 | 0.35 |
Gender (female) | 812 (48.2) | 352 (48.5) | 0.6 | 0.88 |
BMI | 24.0 ± 3.6 | 23.4 ± 3.2 | 18.0 | < 0.001 |
Current smoker | 190 (11.3) | 77 (10.6) | 2.1 | 0.63 |
Regular exercise | 856 (51.0) | 363 (50.1) | 1.7 | 0.70 |
Daily alcohol intake | 350 (20.8) | 159 (22.0) | 2.9 | 0.23 |
Sleep well | 1496 (89.4) | 627 (86.7) | 8.3 | 0.06 |
Skip breakfast more than three times in a week | 49 (2.9) | 23 (3.2) | 1.5 | 0.73 |
Medication | ||||
Antihypertensive Drugs | 1094 (64.9) | 366 (50.4) | 29.6 | < 0.01 |
Oral Blood Glucose Lowering Drugs | 1359 (80.6) | 433 (59.6) | 39.9 | < 0.01 |
Lipid Lowering Drugs | 845 (50.1) | 291 (40.1) | 20.3 | < 0.01 |
Medical History | ||||
History of celebrovascular diseases | 87 (5.2) | 42 (5.8) | 2.8 | 0.53 |
History of heart diseases | 161 (9.5) | 89 (12.3) | 8.7 | 0.05 |
History of renal failure | 9 (0.5) | 1 (0.1) | 6.9 | 0.17 |
CKD | ||||
stage 1 | 232 (13.8) | 77 (10.6) | 9.7 | 0.03 |
stage 2 | 1165 (69.1) | 519 (71.5) | 5.2 | 0.24 |
stage 3 | 280 (16.6) | 127 (17.5) | 2.4 | 0.59 |
stage 4 | 7 (0.4) | 2 (0.3) | 2.4 | 0.61 |
stage 5 | 1 (0.1) | 1 (0.1) | 2.5 | 0.54 |
Systlic Blood Pressure (mmHg) | 130.9 ± 14.8 | 129.9 ± 15.9 | 6.7 | 0.13 |
Diastlic Blood Pressure (mmHg) | 74.4 ± 9.6 | 74.8 ± 9.7 | 3.5 | 0.43 |
HbA1c (%) | 6.2 ± 0.5 | 6.0 ± 0.5 | 31.3 | 0.00 |
LDL (mg/dl) | 116.2 ± 27.2 | 119.0 ± 28.7 | 10.2 | 0.02 |
HDL (mg/dl) | 58.5 ± 15.8 | 59.1 ± 14.9 | 3.9 | 0.38 |
TG (mg/dl) | 127.7 ± 71.9 | 122.8 ± 69.2 | 7.0 | 0.12 |
GOT (IU/L) | 25.0 ± 10.2 | 24.6 ± 9.4 | 3.9 | 0.39 |
GPT (IU/L) | 24.1 ± 13.7 | 23.3 ± 14.4 | 5.6 | 0.20 |
G-GTP (IU/L) | 38.8 ± 39.7 | 36.1 ± 37.2 | 7.1 | 0.11 |
Uric acid (mg/dl) | 5.5 ± 1.4 | 5.5 ± 1.3 | 2.8 | 0.53 |
eGFR (mL/min/1.73 m2) | 73.5 ± 15.3 | 72.2 ± 15.0 | 8.4 | 0.06 |
Albmin (g/dl) | 4.3 ± 0.2 | 4.3 ± 0.3 | 1.5 | 0.74 |
Hemoglobin (g/dl) | 13.8 ± 1.4 | 13.9 ± 1.4 | 11.4 | 0.01 |